secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantern Pharma Inc. (LTRN)
CIK:        0001763950
Form:       8-K
Filed at:   2022-03-22T23:59:59+00:00
Accession:  0001213900-22-013992
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lantern Pharma extends share repurchase program to July 31, 2022; $3.6M remaining authorization.
--------------------------------------------------------------------------------

- Board extended existing share repurchase program through July 31, 2022, with $7M total authorization.
- Since Nov 2021, 475,157 shares repurchased for ~$3.4M; $3.6M remaining as of March 21, 2022.
- Company had $70.7M cash, equivalents, and marketable securities as of Dec 31, 2021.
- Repurchases may occur on open market or privately; program may be suspended at any time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1763950/000121390022013992/0001213900-22-013992-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1763950/000121390022013992/ea157208-8k_lantern.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-013992

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer